Poly Medicure Ltd
NSE:POLYMED
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 390.55
3 128.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Poly Medicure Ltd
Total Equity
Poly Medicure Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Poly Medicure Ltd
NSE:POLYMED
|
Total Equity
â‚ą25.9B
|
CAGR 3-Years
37%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
||
KMS Medisurgi Ltd
BSE:540468
|
Total Equity
â‚ą76.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
||
G
|
GKB Ophthalmics Ltd
BSE:533212
|
Total Equity
â‚ą597.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Choksi Imaging Ltd
BSE:530427
|
Total Equity
â‚ą150.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
C
|
Centenial Surgical Suture Ltd
BSE:531380
|
Total Equity
â‚ą322.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Poly Medicure Ltd
Glance View
Poly Medicure Ltd. engages in the provision and sales of medical devices. The company is headquartered in Faridabad, Haryana. The company went IPO on 2011-12-05. The firm is primarily in the business of manufacture and sale of medical devices. The firm offers a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. The company supplies its products to approximately 110 countries, in Europe, Africa, Americas, Australia, and Asia. Its products include suction control valve, safety arterial cannula, VTM Kit, VLTM kit, blood collection needle with flashback, and pre-filled syringes. The firm operate eight manufacturing facilities across India, China, Egypt, and Italy. In India, it operates five manufacturing facilities, three of which are situated at Faridabad (Haryana), and one each in Jaipur (Rajasthan) and Haridwar (Uttarakhand).
See Also
What is Poly Medicure Ltd's Total Equity?
Total Equity
25.9B
INR
Based on the financial report for Sep 30, 2024, Poly Medicure Ltd's Total Equity amounts to 25.9B INR.
What is Poly Medicure Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
45%
Over the last year, the Total Equity growth was 94%. The average annual Total Equity growth rates for Poly Medicure Ltd have been 37% over the past three years , 45% over the past five years .